Mediastinal lymphadenopathy describes the abnormal enlargement of lymph nodes located within the mediastinum, the central compartment of the thoracic cavity. This finding is rarely a disease itself and is typically a sign of an underlying pathological process, ranging from benign inflammatory reactions to aggressive malignancies. Identifying the specific cause requires a systematic approach that considers patient history, clinical presentation, and advanced imaging characteristics.
Infectious Etiologies
Infectious agents are among the most common causes of mediastinal lymph node enlargement, particularly in younger individuals or immunocompromised patients. These infections often trigger a robust inflammatory response, leading to significant nodal hyperplasia.
Tuberculosis and Fungal Infections
Tuberculosis remains a leading global cause, frequently involving the hilar and paratracheal nodes. The granulomatous inflammation associated with TB can sometimes mimic malignancy on imaging. Similarly, endemic fungal infections such as histoplasmosis, prevalent in regions like the Ohio and Mississippi River valleys, can present with mediastinal lymphadenopathy, often calcified in chronic cases.
Viral and Bacterial Pathogens
Epstein-Barr virus (EBV), responsible for infectious mononucleosis, commonly causes diffuse cervical and mediastinal lymphadenopathy. Less frequently, bacterial pathogens such as nocardia or actinomyces, which typically affect the cervicofacial region or lungs, can extend to involve mediastinal nodes.
Malignant Causes
Malignancy is a critical consideration due to its serious implications and the necessity for prompt intervention. Mediastinal lymphadenopathy can represent primary mediastinal tumors or metastatic spread from extrathoracic primary sites.
Lymphomas
Lymphomas, both Hodgkin and non-Hodgkin types, frequently present with mediastinal involvement. Hodgkin lymphoma, particularly the nodular sclerosis subtype, has a strong predilection for the anterior mediastinum. The pattern of nodal involvement and associated B symptoms are key diagnostic clues.
Metastatic Carcinoma and Other Cancers
Carcinomas originating in the lung, breast, gastric (especially via the left gastric nodal basin), and esophageal regions commonly metastasize to mediastinal nodes. Additionally, primary mediastinal tumors such as thymomas, germ cell tumors, and certain sarcomas can manifest as nodal enlargement.
Inflammatory and Autoimmune Conditions
Systemic inflammatory diseases and autoimmune disorders can cause mediastinal lymphadenopathy through granulomatous or nonspecific inflammatory pathways. This category highlights the importance of a holistic evaluation beyond thoracic pathology.
Sarcoidosis and Other Granulomatous Diseases
Sarcoidosis is a classic cause of bilateral hilar lymphadenopathy (BHL), often accompanied by pulmonary parenchymal disease. This multisystem disorder of unknown etiology features non-caseating granulomas that can affect any organ. Other granulomatous conditions, such as silicosis or berylliosis, may present similarly based on occupational or environmental exposures.
Less Common Inflammatory Causes
Conditions like Castleman disease, a rare lymphoproliferative disorder, can cause significant mediastinal lymphadenopathy, often in a unicentric form. Autoimmune diseases such as rheumatoid arthritis or systemic lupus erythematosus, though less frequent, are also part of the differential diagnosis.
Diagnostic Approach and Evaluation
The evaluation of mediastinal lymphadenopathy is guided by the clinical context and radiographic features. The goal is to characterize the nodes and obtain tissue for definitive diagnosis.
